Borrelia miyamotoi EliSpot

Overview

The Borrelia miyamotoi EliSpot test measures T-cell mediated immune responses to Borrelia miyamotoi using an ELISPOT laboratory method from a blood sample. This cellular immune approach focuses on T-cell activity rather than antibody production, offering insight into immune recognition of this tick-borne organism.

This test may be clinically useful when symptoms or exposure history raise questions around Borrelia miyamotoi and antibody-based testing has provided limited or unclear information. Cellular immune assessment can add context where humoral antibody responses are absent, delayed or difficult to interpret.

Practitioners typically interpret results alongside clinical history, symptom patterns, tick exposure risk, travel history and other relevant laboratory investigations. Reviewing these factors together supports informed discussions with clients about immune response patterns and further investigative considerations.